Results 151 to 160 of about 4,624,933 (258)
Observation of Acetylcholine Secretion on Living Glioblastoma Cells. [PDF]
Milton CB +4 more
europepmc +1 more source
BNC2 exhibits context‐dependent opposing functions across multiple cancer types. This study reveals BNC2 as an oncogenic driver of melanoma proliferation and metastasis through transcriptional activation of PIK3CA. The natural compound TSN simultaneously degrades BNC2 and its oncogenic partner SMAD3 via CRBN‐dependent ubiquitination.
Hui Dai +7 more
wiley +1 more source
An ALKBH3 Inhibitor HUHS199 Suppresses Proliferation of Glioblastoma Cells by Targeting 1-Methyladenosine on GADD45A mRNA. [PDF]
Yamada M +10 more
europepmc +1 more source
Temozolomide treatment activates GSK3β, driving DNMT1 phosphorylation, destabilization, and CD47 promoter hypomethylation in glioblastoma. This epigenetic shift upregulates CD47, enabling TMZ‐treated GBM cells to evade macrophage phagocytosis, survive chemotherapy, and acquire resistance.
Jie Li +11 more
wiley +1 more source
Background: Malignant gliomas, and notably glioblastoma, are highly aggressive brain tumors. Understanding the mechanisms underlying their progression is crucial for developing more effective treatments.
Islam Alzoubi +3 more
core +1 more source
AS1411-Induced Lipidomic Alterations and Therapeutic Insights in U-87 Glioblastoma Cells. [PDF]
Kılıçkaya O, Şahin S.
europepmc +1 more source
TNFRSF19 is an epigenetically silenced regulator of mitophagy in triple‐negative breast cancer. TNFRSF19 deficiency activates the TGFBR1–SMAD3–PINK1 axis to promote mitophagy and confer doxorubicin resistance, whereas decitabine‐mediated restoration of TNFRSF19 suppresses mitophagy and enhances doxorubicin sensitivity, revealing a targetable epigenetic–
Shiyang Liu +7 more
wiley +1 more source
openRecenti studi hanno evidenziato un’opzione terapeutica promettente nell’ambito della medicina oncologica basata sulla combinazione di virus oncolitici (OVs) ingegnerizzati e cellule CAR-T come vettori, da utilizzare per il trattamento di tumori ...
MASON, GIULIA SOFIA
core
IRF1 Inhibits Therapy-Induced Senescence of Glioblastoma Cells Through OAS2. [PDF]
Ma G +5 more
europepmc +1 more source
SOX2 upregulates KAT7 in glioma stem cells, where KAT7 deposits H3K14 acetylation at the RAC2 promoter to activate RAC2 transcription. RAC2‐GTP subsequently promotes PAK1/2/3 phosphorylation, increasing tricarboxylic acid cycle flux and mitochondrial respiration to support glioblastoma malignancy.
Jilong Liu +13 more
wiley +1 more source

